WEST PHARMACEUTICAL SERVICES, INC. Defined Benefit Plan, Expected Return (Loss) on Plan Assets
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Defined Benefit Plan, Expected Return (Loss) on Plan Assets of $400.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-10-26.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan › Defined Benefit Plan, Net Periodic Benefit Cost (Credit)
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets · last filed 2023-10-26
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, expected return (loss) on plan assets for the quarter ending 2023-09-30 was $400.00K, a 50.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, expected return (loss) on plan assets for the quarter ending 2023-06-30 was $300.00K, a 87.50% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, expected return (loss) on plan assets for the quarter ending 2023-03-31 was $300.00K, a 86.36% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. defined benefit plan, expected return (loss) on plan assets for the quarter ending 2022-09-30 was $800.00K, a 72.41% decline year-over-year.
| Period end | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 3 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 6 month | Defined Benefit Plan, Expected Return (Loss) on Plan Assets 9 month |
|---|---|---|---|
| 2023-09-30 | $400.00K 10-Q · filed 2023-10-26 | $700.00K derived: sum of 2 quarters · filed 2023-10-26 | $1.00M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $300.00K 10-Q · filed 2023-07-27 | $600.00K 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $300.00K 10-Q · filed 2023-04-27 | ||
| 2022-09-30 | $800.00K 10-Q · filed 2023-10-26 | $3.20M derived: sum of 2 quarters · filed 2023-10-26 | $5.40M 10-Q · filed 2023-10-26 |
| 2022-06-30 | $2.40M 10-Q · filed 2023-07-27 | $4.60M 10-Q · filed 2023-07-27 | |
| 2022-03-31 | $2.20M 10-Q · filed 2023-04-27 | ||
| 2021-09-30 | $2.90M 10-Q · filed 2022-10-27 | $5.90M derived: sum of 2 quarters · filed 2022-10-27 | $9.00M 10-Q · filed 2022-10-27 |
| 2021-06-30 | $3.00M 10-Q · filed 2022-07-28 | $6.10M 10-Q · filed 2022-07-28 | |
| 2021-03-31 | $3.10M 10-Q · filed 2022-04-28 | ||
| 2020-09-30 | $2.80M 10-Q · filed 2021-10-28 | $5.80M derived: sum of 2 quarters · filed 2021-10-28 | $8.80M 10-Q · filed 2021-10-28 |
| 2020-06-30 | $3.00M 10-Q · filed 2021-07-30 | $6.00M 10-Q · filed 2021-07-30 | |
| 2020-03-31 | $3.00M 10-Q · filed 2021-04-30 | ||
| 2019-09-30 | $3.10M 10-Q · filed 2020-10-23 | $6.00M derived: sum of 2 quarters · filed 2020-10-23 | $8.90M 10-Q · filed 2020-10-23 |
| 2019-06-30 | $2.90M 10-Q · filed 2020-07-24 | $5.80M 10-Q · filed 2020-07-24 | |
| 2019-03-31 | $2.90M 10-Q · filed 2020-04-24 | ||
| 2018-09-30 | $3.90M 10-Q · filed 2019-10-29 | $7.80M derived: sum of 2 quarters · filed 2019-10-29 | $11.70M 10-Q · filed 2019-10-29 |
| 2018-06-30 | $3.90M 10-Q · filed 2019-07-29 | $7.80M 10-Q · filed 2019-07-29 | |
| 2018-03-31 | $3.90M 10-Q · filed 2019-05-08 | ||
| 2017-09-30 | $3.40M 10-Q · filed 2018-10-30 | $6.70M derived: sum of 2 quarters · filed 2018-10-30 | $10.10M 10-Q · filed 2018-10-30 |
| 2017-06-30 | $3.30M 10-Q · filed 2018-07-31 | $6.70M 10-Q · filed 2018-07-31 | |
| 2017-03-31 | $3.40M 10-Q · filed 2018-05-08 | ||
| 2016-09-30 | $3.10M 10-Q · filed 2017-10-31 | $6.30M derived: sum of 2 quarters · filed 2017-10-31 | $9.50M 10-Q · filed 2017-10-31 |
| 2016-06-30 | $3.20M 10-Q · filed 2017-08-01 | $6.30M 10-Q · filed 2017-08-01 | |
| 2016-03-31 | $3.20M 10-Q · filed 2017-05-05 | ||
| 2015-09-30 | $4.90M 10-Q · filed 2016-10-31 | $10.60M derived: sum of 2 quarters · filed 2016-10-31 | $16.30M 10-Q · filed 2016-10-31 |
| 2015-06-30 | $5.70M 10-Q · filed 2016-08-01 | $11.40M 10-Q · filed 2016-08-01 | |
| 2015-03-31 | $5.70M 10-Q · filed 2016-05-06 | ||
| 2014-09-30 | $4.70M 10-Q · filed 2015-11-02 | $9.50M derived: sum of 2 quarters · filed 2015-11-02 | $14.40M 10-Q · filed 2015-11-02 |
| 2014-06-30 | $4.80M 10-Q · filed 2015-08-03 | $9.70M 10-Q · filed 2015-08-03 | |
| 2014-03-31 | $4.80M 10-Q · filed 2015-05-06 | ||
| 2013-09-30 | $4.30M 10-Q · filed 2014-11-03 | $8.60M derived: sum of 2 quarters · filed 2014-11-03 | $12.90M 10-Q · filed 2014-11-03 |
| 2013-06-30 | $4.30M 10-Q · filed 2014-08-01 | $8.60M 10-Q · filed 2014-08-01 | |
| 2013-03-31 | $4.30M 10-Q · filed 2014-05-08 | ||
| 2012-09-30 | $4.00M 10-Q · filed 2013-11-04 | $8.10M derived: sum of 2 quarters · filed 2013-11-04 | $12.20M 10-Q · filed 2013-11-04 |
| 2012-06-30 | $4.10M 10-Q · filed 2013-08-05 | $8.10M 10-Q · filed 2013-08-05 | |
| 2012-03-31 | $4.10M 10-Q · filed 2013-05-06 | ||
| 2011-09-30 | $4.10M 10-Q · filed 2012-11-05 | $8.60M derived: sum of 2 quarters · filed 2012-11-05 | $12.10M 10-Q · filed 2012-11-05 |
| 2011-06-30 | $4.50M 10-Q · filed 2012-08-06 | $7.90M 10-Q · filed 2012-08-06 | |
| 2011-03-31 | $4.00M 10-Q · filed 2012-05-04 | ||
| 2010-09-30 | $4.00M 10-Q · filed 2011-11-07 | $7.50M derived: sum of 2 quarters · filed 2011-11-07 | $11.00M 10-Q · filed 2011-11-07 |
| 2010-06-30 | $3.50M 10-Q/A · filed 2011-08-08 | $7.00M 10-Q/A · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |